Medical Condition News

RSS

$Medtronic announces U.S. launch of Kyphon Xpede Bone Cement for spinal fracture treatment$

Medtronic announces U.S. launch of Kyphon Xpede Bone Cement for spinal fracture treatment

Medtronic, Inc. today announced the U.S. launch of Kyphon Xpede Bone Cement, a quick-to-dough polymethylmethacrylate bone cement for use in the treatment of spinal fractures with minimally invasive Kyphon Balloon Kyphoplasty.

From Medtronic 17 May 2011

SYMBICORT long-term comparative study data in African American asthma patients presented at ATS 2011

AstraZeneca today announced results from a long-term study comparing SYMBICORT Inhalation Aerosol 160/4.5 mcg with budesonide pressurized metered-dose inhaler 160 mcg in self-reported African American patients with moderate to severe persistent asthma.

17 May 2011

Abcc10 might help counter resistance and extend effectiveness of anticancer drugs

Today's anticancer drugs often work wonders against malignancies, but sometimes tumors become resistant to the effects of such drugs, and treatment fails. Medical researchers would like to find ways of counteracting such resistance, but first they must understand why and how it happens.

17 May 2011

GPSA, Sanofi partner to develop and commercialize GBR 500 for inflammatory disease treatment

Glenmark Pharmaceuticals S.A, a wholly owned subsidiary of Glenmark Pharmaceuticals Limited India, announced today that it has entered into an agreement with Sanofi to grant Sanofi a license for the development and commercialization of GBR 500, a novel monoclonal antibody for the treatment of Crohn's Disease and other inflammatory conditions.

17 May 2011

Perrigo's ANDA for generic Zantac 150 receives FDA final approval to treat heartburn

Perrigo Company today announced that it has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug application for over-the-counter Ranitidine 150, a generic version of Zantac 150.

17 May 2011

Early stages of Alzheimer’s difficult to detect: Study

According to a new study, more than half of people who develop Alzheimer's disease before the age of 60 are initially misdiagnosed as having other kinds of brain disease when they do not have memory problems. The research is published in the May 17, 2011, print issue of Neurology, the medical journal of the American Academy of Neurology.

17 May 2011

Imaginary bugs flummox dermatologists

It is known that some people have the “delusional bug syndrome” and are convinced that bugs, worms, germs, or other creepy crawlers are infesting their skin and often see skin doctor after skin doctor to find out what is causing the infestation. Often, patients bring in samples of the insect and request a skin biopsy.

17 May 2011

Calypso System can precisely deliver radiation in post-prostatectomy patients

Calypso Medical Technologies, Inc., developer of GPS for the Body® technology used for the precise tracking of cancerous tumors during radiation therapy, is exhibiting at the American Urological Association Annual Meeting (booth 4337) and will discuss recent clinical findings suggesting that the Calypso® System can be used to more precisely deliver radiation in post-prostatectomy patients.

16 May 2011

Positive pirfenidone data in idiopathic pulmonary fibrosis to be presented at ATS conference

InterMune, Inc. today announced that an oral presentation and a poster presentation related to the company's development program for pirfenidone in idiopathic pulmonary fibrosis will be presented at the 2011 International Conference of the American Thoracic Society, being held in Denver May 13-18, 2011.

16 May 2011

Mylan introduces Bromfenac Ophthalmic Solution for cataract postoperative inflammation treatment

Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Bromfenac Ophthalmic Solution, 0.09%, based on a development and supply agreement with Coastal Pharmaceuticals.

16 May 2011

Continuous positive airway pressure can increase alertness, improve quality of life in OSA patients

Continuous positive airway pressure, or CPAP, can increase alertness and even improve quality of life for sufferers of obstructive sleep apnea, even if their symptoms are minimal, according to a study conducted by researchers in Europe.

16 May 2011

Accelerated aging process of cells may play a role in lung inflammation linked with COPD

Changes in the ability of lung cells to divide may play a role in initiating or prolonging lung tissue inflammation, a hallmark of chronic obstructive pulmonary disease (COPD), according to a study conducted by researchers in France.

16 May 2011

Six-minute walking distance test effectively determines disease severity in COPD

The six-minute walking distance test, a test that measures a patient's ability to tolerate exercise and physical activity, is an effective tool for understanding disease severity in patients with chronic obstructive pulmonary disease, according to a three-year global study of patients with COPD sponsored by drug manufacturer GlaxoSmithKline.

16 May 2011

Journal of Burn Care & Research publishes Caldolor clinical study data in hospitalized patients

Cumberland Pharmaceuticals Inc. today announced that results from a clinical study evaluating the safety and efficacy of Caldolor Injection in treating fever and pain in hospitalized burn patients was published in Volume 32, Number 1 of the Journal of Burn Care & Research.

16 May 2011

Amylin files lawsuit against Eli Lilly for improper commercialization of exenatide

Amylin Pharmaceuticals, Inc. today announced that it has filed a lawsuit against Eli Lilly and Company in the United States District Court for the Southern District of California, alleging that Lilly is engaging in anticompetitive activity and breaching its strategic alliance agreements with Amylin to maximize commercialization of exenatide.

16 May 2011

Positive results from EXPAREL Phase 3 study to be presented at ASCRS Annual Scientific Meeting

Pacira Pharmaceuticals, Inc., an emerging specialty pharmaceutical company, today announced that positive results from its Phase 3 study evaluating EXPAREL in patients following hemorrhoidectomy will be presented at the 2011 American Society of Colon and Rectal Surgeons Annual Scientific Meeting in Vancouver, British Columbia.

16 May 2011

New study on role of psychotherapy in personality disorders

This study shows that cluster A psychopathology is not a contraindication to benefit from psychotherapy. This is especially true for more intensive forms like inpatient and day hospital treatment.

16 May 2011

Study finds link between heart failure hospitalization and readmission rates

Researchers compared hospitalization rates and rehospitalization rates of patients admitted for heart attack and for heart failure. Heart attack admissions are considered non-discretionary, whereas, heart failure admissions are considered more discretionary.

16 May 2011

Study finds no potential cardiovascular risks of ADHD medications in children, adolescents

Despite recent concerns that medications for attention deficit hyperactivity disorder could increase the risk of cardiovascular events in children and adolescents, an observational study conducted by researchers at the University of Pennsylvania School of Medicine and HealthCore Inc. finds they are no more likely to die from a severe cardiovascular event than those who do not take the drugs.

16 May 2011

International researchers discover new aspect of 'metabolic transformation'

An international research team led by Dr. Tak Mak, Director, The Campbell Family Institute for Breast Cancer Research at Princess Margaret Hospital (PMH), has discovered a new aspect of "metabolic transformation", the process whereby tumour cells adapt and survive under conditions that would kill normal cells.

16 May 2011

Medical Condition News

Medtronic announces U.S. launch of Kyphon Xpede Bone Cement for spinal fracture treatment

SYMBICORT long-term comparative study data in African American asthma patients presented at ATS 2011

Abcc10 might help counter resistance and extend effectiveness of anticancer drugs

GPSA, Sanofi partner to develop and commercialize GBR 500 for inflammatory disease treatment

Perrigo's ANDA for generic Zantac 150 receives FDA final approval to treat heartburn

Early stages of Alzheimer’s difficult to detect: Study

Imaginary bugs flummox dermatologists

Calypso System can precisely deliver radiation in post-prostatectomy patients

Positive pirfenidone data in idiopathic pulmonary fibrosis to be presented at ATS conference

Mylan introduces Bromfenac Ophthalmic Solution for cataract postoperative inflammation treatment

Continuous positive airway pressure can increase alertness, improve quality of life in OSA patients

Accelerated aging process of cells may play a role in lung inflammation linked with COPD

Six-minute walking distance test effectively determines disease severity in COPD

Journal of Burn Care & Research publishes Caldolor clinical study data in hospitalized patients

Amylin files lawsuit against Eli Lilly for improper commercialization of exenatide

Positive results from EXPAREL Phase 3 study to be presented at ASCRS Annual Scientific Meeting

New study on role of psychotherapy in personality disorders

Study finds link between heart failure hospitalization and readmission rates

Study finds no potential cardiovascular risks of ADHD medications in children, adolescents

International researchers discover new aspect of 'metabolic transformation'

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Latest News